Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Context: With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the “Geroscience Hypothesis,” which posits that manipulation of fundamental aging mechanisms will delay the appearance or severity of multiple chronic diseases because these diseases share aging as the underlying risk factor. In this context, one fundamental aging mechanism that has received considerable attention recently as contributing to multiple age-related morbidities is cellular senescence. This mini-review provides an overview on cellular senescence with a focus on its role in mediating age-related bone loss. Methods: This summary is based on the authors’ knowledge of the field supplemented by a PubMed search using the terms “senescence,” “aging,” and “bone.” Results: There is compelling evidence from preclinical models and supportive human data demonstrating an increase in senescent cells in the bone microenvironment with aging. These cells produce a proinflammatory secretome that leads to increased bone resorption and decreased bone formation, and approaches that either eliminate senescent cells or impair the production of their proinflammatory secretome have been shown to prevent age-related bone loss in mice. Conclusions: Targeting cellular senescence represents a novel therapeutic strategy to prevent not only bone loss but potentially multiple age-related diseases simultaneously.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The number of senescent cells increases with aging and has been linked to the development of age-related diseases, such as DM, hypertension, atherosclerosis, and osteoporosis [36].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [36]
Citations
Cites
1 retracted
RETRACTED: Quercetin: A flavonol with multifaceted therapeutic applications?
D'Andrea, G. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.09.018 · Cited by 721
RetractedThe limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citationWorld-wide Projections for Hip Fracture
Gullberg, B., Johnell, O., & Kanis, J. A. (1997) · Osteoporosis International · doi:10.1007/pl00004148 · Cited by 2,285
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
Self-citationPostmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Cited by
Items 101–142 of 142
Crab shell polypeptides enhance calcium dynamics and osteogenic activity in osteoporosis
Dong, X., Zhang, G., Sun, C., Zhang, H., Zhen, J., Li, X., Xu, X., Liu, J., Zhao, X., Zhang, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1605422 · Cited by 2
Frontiers in Spinal Neurosurgery
Wang, J. J., Wang, G., Lv, X., Sun, Z., & Mahapure, K. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000270 · Cited by 2
HDL levels modulate the impact of type 2 diabetes susceptibility alleles in older adults
Sullivan, S. O. ’., Hageh, C. A., Henschel, A., Chacar, S., Abchee, A., Zalloua, P., & Nader, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02039-7 · Cited by 2
Jiba, U., Adil, M., Rafiya, K., Hasan, N., Ahmad, F. J., & Amin, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107470 · Cited by 2
Recent advances in models for screening potential osteoporosis drugs
Merlotti, D., Materozzi, M., Picchioni, T., Bianciardi, S., Alessandri, M., Nuti, R., & Gennari, L. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1480609 · Cited by 2
Khosla, S., Monroe, D. G., & Farr, J. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00011-0 · Cited by 2
Self-citationImportancia de Biomarcadores en la Osteoporosis: Avances en la Gerociencia del Adulto Mayor
Cedeño‐Veloz, B. A., & Martínez‐Velilla, N. (2023) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2023.101390 · Cited by 2
The Role of Estrogen Receptor α Signaling in the Regulation of Bone Mass
Farman, H. H. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid ExcessPreprint
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Yano, S., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4178844 · Cited by 2
Cellular senescence links muscle atrophy and posttraumatic osteoarthritis after ACL injury
Keeble, A. R., Owen, A. M., Gonzalez‐Velez, S., Thomas, N. T., Brightwell, C. R., Balawender, P. J., O'Daniel, M. G., Weiss, H., Noehren, H., Thompson, H. J., et al. (2026) · Function · doi:10.1152/function.017.2026 · Cited by 1
Elsabaawy, M., Eissa, M., Atef, M., Rizk, S., Awad, H., Masoud, B. M., Badawy, A., & Naguib, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-55248-8 · Cited by 1
Geroscience and Management of Osteoporosis in Older Adults
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_19 · Cited by 1
Cellular senescence as a pathogenic factor and potential therapeutic target in osteoporosis
Larrea, L. P., Rodríguez, M. D. B., Naves‐Díaz, M., & Alonso, C. G. (2023) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.20960/revosteoporosmetabminer.00013 · Cited by 1
Osteogenic Cells and Microenvironment of Early Bone Development and Clinical Implication
Kim, K., & Lee, C. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002037 · Cited by 1
Molecular Mechanisms and Cardiovascular Ramifications of Doxorubicin-induced Senescence
Abdelgawad, I. Y. (2023) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
The Nonfatal Clinical Manifestations of Ageing
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_5
Li, Z., Liu, X., Liu, X., Du, Y., Zhu, Y., Lv, L., Zhang, X., Liu, Y., Zhang, P., & Zhou, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-115769/v1
Novel probes, carriers and prodrugs to target senescent cells in vivo
Lozano‐Torres, B. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/172175
Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid ExcessPreprint
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., Trada, E., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4089144
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
The Aging of Cells: Cellular Senescence and Implications for Age-Related Diseases
Kim, A., & Yoo, J. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4847
Cedeño‐Veloz, B. A. (2024) · Academica-e (Universidad Pública de Navarra) · doi:10.48035/tesis/2454/48053
RPE Senescence and Its Implication in Age-Related Macular Degeneration
Wang, S., Zhou, Q., & Tong, Y. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_6
Chyngyshpaev, D. (2024) · Bulletin of Science and Practice · doi:10.33619/2414-2948/108/29
Sullivan, S. O. ’., Hageh, C. A., Henschel, A., Chacar, S., Abchee, A., Zalloua, P., & Nader, M. (2024) · Figshare · doi:10.6084/m9.figshare.26684367
Puebla-Huerta, A. (2023) · Universidad de Chile · doi:10.58011/v8aa-fk61
Sullivan, S. O. ’., Hageh, C. A., Henschel, A., Chacar, S., Abchee, A., Zalloua, P., & Nader, M. (2024) · Figshare · doi:10.6084/m9.figshare.26684370
Senescence cells in aging - Approaches, Challenges and Opportunities
Lokvančić, H. (2024) · Bioengineering Studies · doi:10.37868/bes.v5i2.id312
内因性グルココルチコイド過剰症患者における骨と血管障害の併存
矢野(井上), 千. (2023) · Institutional Repositories DataBase (IRDB)
Wu, J., Gong, R., Wen, Y., Kong, S., Yang, P., & Deng, X. (2026) · Journal of Biomaterials Applications · doi:10.1177/08853282261449941
Jami, S. A., Dapaah, E., Hong, P., Jiamao, H., & Hosain, M. T. (2026) · Next research. · doi:10.1016/j.nexres.2026.102123
Vrablikova, K., Hoza, P., Párová, H., Rybar, M., Kaur, J., Khosla, S., Monroe, D. G., Mikyskova, P. S., & Palička, V. (2026) · Physiological Research · doi:10.33549/physiolres.935778
Self-citationLiu, Z., Han, D., Wang, Y., Li, H., Pei, X., & Song, Z. (2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2026.13277
Social Adversity and Epigenetic Aging in Oral Conditions and Multimorbidity
Esemezie, A. O. (2025) · Scholarship@Western (Western University)
Zhong, Y., Wu, G., Xiong, S., Zhang, Y., Guo, Z., Lu, W., Lan, Q., Zeng, Z., Chen, D., Guo, H., et al. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10959-0
Tong, X., Zhou, Y., Cao, Y., & Han, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1950788
Li, J., Zhang, L., Ren, Y., Wang, J., Zhang, P., 申倩然, Wang, Y., Yu, Y., Cheng, Z., Wang, Q., et al. (2026) · Theranostics · doi:10.7150/thno.129818
Brooks, H. W., Cusick, N. C., Wu, S., & Farr, J. N. (2026) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2026.102203
Self-citationRole Of Pomegranate Phenolic Antioxidants In Disease Management
Saini, M. J. A. K. (2021) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2021.12.02.10
Advancements in Pharmacological Treatments for Bone Metabolic Diseases
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8986-1
Peng, X., Zhou, X., Ying Yin, Beibei Luo, Liu, Y., & Yang, C. (2022) · doi:10.3389/fbioe.2022.870324.s001
Metadata
- Authors
- Khosla, S., Farr, J. N., & Kirkland, J. L.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Khosla, Sundeep
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-02-07
- Volume
- 103
- Issue
- 4
- Pages
- 1282-1290
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6276719
- OpenAlex
- W2789912326
- Cited by
- 130
- References
- 42
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 19 · 2023: 11 · 2022: 13 · 2021: 21 · 2020: 24 · 2019: 17 · 2018: 7
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG048792, P01AG004875, R37AG013925)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR070241, R01AR027065)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- cellular senescence, senile osteoporosis, senolytics, senescence-associated secretome, bone loss, bone microenvironment, bone resorption, bone formation, aging, osteoporotic fractures, comorbidities
- MeSH terms
- Aging, Animals, Bone and Bones, Chronic Disease, Humans, Osteoporosis, Comorbidity, Bone Remodeling, Cellular Senescence, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.